Logo image of LFCR

LIFECORE BIOMEDICAL INC (LFCR) Stock Analyst Ratings

NASDAQ:LFCR - Nasdaq - US5147661046 - Common Stock - Currency: USD

5.94  +0.22 (+3.85%)

After market: 5.94 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to LFCR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.67. This target is 45.96% above the current price.
LFCR was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about LFCR.
In the previous month the buy percentage consensus was at a similar level.
LFCR was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

LFCR Historical Analyst RatingsLFCR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 5.947.078.678.6710.50 - 19.02% 45.96% 45.96% 76.77%

Related screens

LFCR Current Analyst RatingLFCR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-01-03 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2024-11-22 Craig-Hallum Maintains Buy -> Buy
2024-09-05 Craig-Hallum Initiate Buy
2024-08-28 Barrington Research Downgrade Outperform -> Market Perform
2023-09-01 Barrington Research Maintains Outperform -> Outperform
2023-09-01 Stephens & Co. Maintains Equal-Weight -> Equal-Weight
2023-06-02 Barrington Research Maintains Outperform -> Outperform
2023-05-24 Barrington Research Maintains Outperform -> Outperform
2023-03-21 Barrington Research Maintains Outperform
2023-03-20 Barrington Research Maintains Outperform
2023-03-20 Stephens & Co. Downgrade Overweight -> Equal-Weight
2023-03-17 Stephens & Co. Reiterate Overweight